Paul Wilczynski
A
Moderna today announced that clinical trial data from its research assay confirm its updated COVID-19 vaccine, which is pending approval by the U.S. Food and Drug Administration for the fall 2023 vaccination season, generates an 8.7-fold increase in neutralizing antibodies in humans against BA.2.86
10:39 AM - Sep 06, 2023
Avatar Avatar Avatar
0
3
17
Kris Y
A
In response to Paul Wilczynski.
Great, but how long does it last?
10:52 AM - Sep 06, 2023
1
0
Paul Wilczynski
A
In response to Kris Y.
10:53 AM - Sep 06, 2023
1
0
Kris Y
A
In response to Paul Wilczynski.
This is good news! The problem with the RNA vaccines is that the immunity wanes in weeks. Which is not the case with Novavax, which most of us don’t have access to.
11:02 AM - Sep 06, 2023
0
0

 

{{ notificationModalContent }} {{ promptModalMessage }}